Samantha Stasi, MS CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 555 E Broadway Ave Ste 100, Jackson, WY 83001 Phone: 307-739-7306 |
Lara Cilo, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1300 W. Valley Springs Road, Jackson, WY 83001 Phone: 307-733-3971 |
Mrs. Tia L Johnson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 555 E Broadway Ave # 100, Jackson, WY 83001 Phone: 307-739-1864 |
Aaron Bilotta Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 185 South Willow Street, Jackson, WY 83001 Phone: 307-733-3791 |
Patricia Drui, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 555 E Broadway Ave, Suite 100, Jackson, WY 83001 Phone: 307-739-1864 |
Christopher Smithwick Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 625 E Broadway Ave, Jackson, WY 83001 Phone: 307-733-3636 |
Megan Santacroce Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 185 South Willow, Jackson, WY 83001 Phone: 307-733-3791 |
Anne Barrett Hazard, MS, CCCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1822 Josephine Loop, Jackson, WY 83001 Phone: 622-207-0181 |
Kate Wienman, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 175 E Solitude Dr, Jackson, WY 83001 Phone: 260-341-5288 |
Ms. Hollis Magee, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 370 Redmond St, Jackson, WY 83001 Phone: 215-783-8962 |
Carol Bocker, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 555 E Broadway Ave, Suite 100, Jackson, WY 83001 Phone: 307-739-1864 |
Jacqueline Hart Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 806 Morgan Ln, Jackson, WY 83001 Phone: 307-734-3932 |
News Archive
Synthon has announced that its subsidiary Synthon Pharmaceuticals, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application for tadalafil tablets, 20 mg on April 13, 2012. Synthon's product is a generic and bioequivalent version of Eli Lilly & Co and United Therapeutics' Adcirca® tablets, which are indicated for the treatment of pulmonary arterial hypertension to improve exercise ability.
If continuing increases in health care costs are inevitable, as some economists predict, is it possible for health care delivery reform to succeed in reducing the overall burden of health care expenditures on the U.S. economy? According to the results of a new study, the focus should shift from cost control to improving utilization rates and quality outcomes, as described in detail in an article in Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Collaborating with researchers from the Northwestern University Feinberg School of Medicine in Chicago, a research team at Wayne State University's School of Medicine led by Kezhong Zhang, Ph.D., has contributed to an important discovery in the inflammatory stress mechanism and specific inhibitor for the treatment of rheumatoid arthritis.
New, proposed regulations — which result from the health overhaul — were issued yesterday by the Department of Health and Human Services and would require health insurers to justify proposed double-digit premium increases. In addition, administration officials signaled their plan to step-up their reviews of insurance rates if state regulators are not adequately protecting consumers.
SelectHealth is pleased to announce the recipients of the 2012 Select 25 award. The nonprofit health insurance carrier will give $2,500 to each of the 25 winners to assist them in their efforts to improve health and wellness, or to serve populations with special needs.
› Verified 1 days ago